Levetiracetam
NDC 65219-046, levetiracetam, injection, from Fresenius Kabi USA, LLC.
- Product NDC
- 65219-046
- Status
- Listed
- Labeler
- Fresenius Kabi USA, LLC
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208619
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/65219-046 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LEVETIRACETAM15 mg/mL
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65219-046-71 | 65219004671 | 10 BAG in 1 CARTON (65219-046-71) / 100 mL in 1 BAG (65219-046-21) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/da858849-1d18-4d38-b53d-d4dd1cd8fabcMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=65219-046
Use it
Look up 65219-046 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65219-046 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65219-046. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.